A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial

A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial

Background: Chronic lymphocytic leukemia (CLL) is characterized by accumulation of B cells in blood, lymphoid tissues and bone marrow. Addition of rituximab to CLL chemotherapy regimens has been associated with improved survival. The aim of this study was to establish efficacy and safety of Zytux™...

Full description

Bibliographic Details
Main Authors: Gholamreza Toogeh, Mohammad Faranoush, Seyed Mohsen Razavi, Hassan Jalaeikhoo, Abolghasem Allahyari, Mohammad Reza Ravanbod, Fariba Zarrabi, Vahid Fallahazad, Ehsan Rezaei Darzi, Shadi Sadat Alizadeh Fard
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2018-04-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Chronic lymphocytic leukemia
Rituximab
Zytux™
Mabthera®
Clinical trial
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/771

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/771

Similar Items